Crossmark

Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-018-3092-7

Published Online: 2018-12-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cho, Yuri

Park, Youn Su

Kim, Hwi Young

Kim, Won https://orcid.org/0000-0002-2926-1007
Lee, Heon Ju

Kim, Dong Joon
Funding

Funding for this research was provided by:

2014 Korean Association for the Study of the Liver Research Fund (N/A)
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 6 September 2018

Accepted: 30 November 2018

First Online: 22 December 2018

Ethics approval and consent to participate

: The trial has been approved by the Institutional Review Board (IRB) of Seoul National University Boramae Medical Center and by the IRBs of the 14 participating centers (Hallym University Medical Center-Chuncheon, Pusan National University Hospital, Pusan National University Yangsan Hospital, Daegu Catholic University Medical Center, Ulsan University Hospital, St. Vincent’s Hospital, Korea University Ansan Hospital, Hanyang University Guri Hospital, Chonbuk National University Hospital, Yonsei University Wonju Severance Christian Hospital, GangNeung Asan Hospital, Uijeongbu St. Mary’s Hospital, Wonkwang University Hospital, and Gyeongsang National University Hospital). Informed consent will be obtained from all participants in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below